FDA Drug Application (020622) for COPAXONE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number020622
Product Number001
FormFOR SOLUTION;SUBCUTANEOUS
Dosage20MG/VIAL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCOPAXONE
Active IngredientGLATIRAMER ACETATE



Back to FDA Applications sponsored by TEVA PHARMS USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.